fda - Search News

FDA approves new pain medicine

CNN on MSN · 2d

FDA approves first new type of pain medication in 25 years

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.

Hosted on MSN · 1d

FDA approves 1st new class of opioid-free painkillers in over 20 years

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

U.S. News & World Report · 1d

What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.

FDA, Chocolate-covered almonds

YAHOO!News · 1d

Chocolate recall elevated to highest risk level by FDA due to risk of 'adverse health consequences’

A major chocolate recall has been upgraded to the highest possible risk level.

Austin American-Statesman · 1d

FDA upgrades Cal Yee Farm chocolate recall to 'potential deadly'; products sold in Texas

Last month, the FDA announced a recall for multiple products from Cal Yee Farm including chocolate and yogurt covered products.

KCRA Sacramento on MSN · 1d

FDA sounds alarm on 'potentially deadly' Bay Area chocolate

The Food and Drug Administration has elevated three chocolates made by a Fairfield manufacturer to the highest-level recall classification.

Hosted on MSN1d

FDA approves 'ketamine' nasal spray for depression — here's everything you need to know

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

4don MSN

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

1don MSN

What is Non-Opioid Pain Medication? Journavx Approved by FDA

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

Targeted Oncology1h

The Targeted Pulse: Sniffing out the Latest From ASCO GI 2025 and Fresh FDA Activity

Aspirin reduced recurrence by 50% in PIK3CA-mutated colorectal cancer, the DCISionRT test earned FDA breakthrough status for ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results